Pri-Med Podcasts

Latest Episodes:

Using DOACs for Valvular Atrial Fibrillation - Frankly Speaking Ep 249 Nov 08, 2021

Show notes

Credits: 0.25 AMA PRA Category 1 Credit™

CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-249

Overview: For non-valvular atrial fibrillation, physicians, patients, and guideline organizations all prefer direct oral anticoagulants (DOACs) over vitamin K antagonists, such as warfarin, for thromboembolic prophylaxis. For those with valvular atrial fibrillation, the data for safety and efficacy have been limited because randomized trials comparing DOACs to warfarin often exclude patients with valvular atrial fibrillation. Join us to explore new data that shed light on the use of DOACs in valvular atrial fibrillation.

Episode resource links:

Dawwas GK, Dietrich E, Cuker A, Barnes GD, Leonard CE, Lewis JD. Effectiveness and Safety of Direct Oral Anticoagulants Versus Warfarin in Patients With Valvular Atrial Fibrillation : A Population-Based Cohort Study. Ann Intern Med. 2021;174(7):910-919.

Guest: Alan Ehrlich MD, FAAFP

Music Credit: Richard Onorato

Aspirin—Not Really for Primary Prevention - Frankly Speaking Ep 248 Nov 01, 2021

Show notes

Credits: 0.25 AMA PRA Category 1 Credit™

CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-248

Overview: Join us to hear a discussion on the important changes the AHA/ACC and USPSTF have made to their positions on the use of aspirin for primary prevention of cardiovascular disease. The organizations note that while aspirin for primary prevention lowers the risk of a myocardial infarction, its harmful effects may outweigh its benefits. Learn the aspirin recommendations for your patients in their 40s, 50s, and 60s who are at higher risk for a cardiovascular event.

Episode resource links:

Guest: Jill M. Terrien PhD, ANP-BC

Music Credit: Richard Onorato

Expanding Access to IUDs: Oct 31, 2021

Show notes

Credits: 0.25 AMA PRA Category 1 Credit™

CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/expanding-access-to-IUDs

Overview: In this concise and informative podcast, listen to family planning expert Katharine White, MD, review the current landscape of intrauterine device (IUD) options available to your patients. She will describe the current approved IUD options and a case example to help you understand how to counsel patients about IUDs. After listening, you will be equipped to identify patients who would benefit from IUDs and help these patients pick the best one for them. If you are interested in getting further hands-on training related to IUD insertion, management, and removal, check out the list of resources provided with this activity that can enable you to incorporate this important skill into your practice.

Guest: Katharine O’Connell White, MD, MPH

Early Action in HCC: The Role of Primary Care in Hepatocellular Carcinoma Management Oct 31, 2021

Show notes

Credits: 0.25 AMA PRA Category 1 Credit™

CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/early-action-in-hcc-episode-three

Overview: This podcast is the third in a three-part series addressing the urgency for early identification and improved care for patients with hepatocellular carcinoma (HCC). In this episode, two experts discuss exciting changes in the HCC treatment landscape, and how primary care providers can help with follow-up and care coordination.

Guest: Ghassan Abou-Alfa, MD, MBA & Amit G. Singal, MD, MS

A Fishy Method to Prevent Migraines - Frankly Speaking Ep 247 Oct 26, 2021

Show notes

Credits: 0.25 AMA PRA Category 1 Credit™

CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-247

Overview: When it comes to chronic migraines, your first-line prevention is probably medication, but according to a new study, it may not have to be. Certain foods may play a role in increasing and decreasing migraine recurrence. Join us to review a recent randomized controlled trial aimed at preventing migraines in those with chronic migraines.

Episode resource links:

BMJ 2021; 374 :n1448 doi:10.1136/bmj.n1448; doi: https://doi.org/10.1136/bmj.n1448
The association of dietary patterns with migraine attack frequency in migrainous women. Nutritional Neuroscience 23:9, pages 724-730

Guest: Alan Ehrlich MD, FAAFP

Music Credit: Richard Onorato

Early Action in HCC: Learning From Past Experience Oct 22, 2021

Show notes

Credits: 0.25 AMA PRA Category 1 Credit™

CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/early-action-in-hcc-episode-two

Overview: This podcast is the second in a three-part series addressing the urgency for early identification and improved care for patients with hepatocellular carcinoma (HCC). In this episode, two experts discuss three HCC patient cases and examine the role of screening and referral in their disease course trajectory.

Guest: Ghassan Abou-Alfa, MD, MBA & Amit G. Singal, MD, MS

Muscle Relaxants for Low Back Pain: Are They Worth the Risk? - Frankly Speaking Ep 246 Oct 18, 2021

Show notes

Credits: 0.25 AMA PRA Category 1 Credit™

CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-246

Overview: Low back pain often leads to disability and loss of income and is a significant burden on patients and the healthcare system. While muscle relaxants are the third most common prescribed drugs in the treatment of low back pain, recent data demonstrating its use and efficacy are limited. This session discusses a recent systematic review of the safety, efficacy, and accepted use of muscle relaxants in the treatment of low back pain. Don’t miss this opportunity to learn how to provide low back pain treatments that have clear benefits for your patients.

Episode resource links:

Cashin A G, Folly T, Bagg M K, Wewege M A, Jones M D, Ferraro M C et al. Efficacy, acceptability, and safety of muscle relaxants for adults with non-specific low back pain: systematic review and meta-analysis BMJ 2021; 374 :n1446 doi:10.1136/bmj.n1446 https://pubmed.ncbi.nlm.nih.gov/34233900/

Guest: Jill M. Terrien PhD, ANP-BC

Music Credit: Richard Onorato

Populations at High-Risk for Influenza: Children Oct 15, 2021

Show notes

Credits: 0.25 AMA PRA Category 1 Credit™

CME/CE Information and Claim Credit:

Overview: In this short podcast, you will hear guideline-based answers to important questions about managing influenza in the pediatric population. Find out which children are considered high risk for complications and what those risks mean for vaccine selection. Hear expert tips on how to discuss the sensitive issue of influenza vaccination with vaccine-hesitant parents. Know how to accurately diagnose influenza in children in the midst of the COVID-19 pandemic. And lastly, learn which influenza treatments are approved for children and the role antivirals play in influenza prophylaxis in this population.

Hosts: Robert H. Hopkins Jr., MD, FACP, FAAP; Charles Vega, MD, FAAFP
Executive Producer: Margaret Oliverio, MD

Populations at High-Risk for Influenza: Cardiometabolic Disease Oct 15, 2021

Show notes

Credits: 0.25 AMA PRA Category 1 Credit™

CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/influenza-populations-at-high-risk-3

Overview: Join us to discover why it is important to prevent influenza and treat patients with influenza who have cardiometabolic disease. After this brief podcast, you will be able to identify the types of cardiovascular and metabolic diseases that put patients at high risk of influenza complications and determine which patients should get the high-dose influenza vaccine, according to recent data. You will also be able to answer the question of whether anti-influenza drugs affect the risk of incident cardiovascular events. Find out all this and more to protect your patients with cardiometabolic disease this influenza season.

Hosts: Erin D. Michos, MD, MHS, FACC, FAHA, FASE, FASPC; Charles Vega, MD, FAAFP
Executive Producer: Margaret Oliverio, MD

Populations at High-Risk for Influenza: Older Adults Oct 15, 2021

Show notes

Credits: 0.25 AMA PRA Category 1 Credit™

CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/influenza-populations-at-high-risk-2

Overview:

This expert-led podcast arms you with what you need to know to effectively manage influenza in older adults, a population at increased risk for complications. Get the latest guidance on everything from choosing the appropriate vaccine for this age group to preventing the spread of influenza in long-term care facilities. Hear the most up-to-date recommendations for how to diagnose and treat older adults with influenza and find out if there are any risks associated with antivirals for this patient population. If you provide care to older adults this influenza season, you can’t miss this session.

Hosts: Mary W. Montgomery, MD; Charles Vega, MD, FAAFP
Executive Producer: Margaret Oliverio, MD

Our TOPPODCAST Picks

Follow Us

Stay Connected

Related Podcasts

Links

Stay Connected